Navigation Links
Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
Date:1/8/2010

DURHAM, N.C., Jan. 8 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) announced today that its common stock has been approved for listing on the NASDAQ Capital Market.

"Moving up from the OTC Bulletin Board to the NASDAQ is a very important milestone for our company," said company chairman and CEO Chris J. Stern. "Being listed on the NASDAQ provides us with greater visibility for our company, more liquidity for our stock and the opportunity to further expand our investor base. I believe that this move will deliver increased value for our shareholders now and down the road."

Trading on the NASDAQ is excepted to begin next week. The company will announce further details in due course. Prior to the listing change, Oxygen Biotherapeutics, Inc. shares will continue to trade on the Over-the-Counter (OTC) Bulletin Board.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has developed a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(TM)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle cell crisis, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes wounds and ulcers, and cosmetic applications which are being marketed under the Dermacyte name. More information is available at www.oxybiomed.com.

SOURCE Oxygen Biotherapeutics, Inc.

RELATED LINKS
http;//www.oxybiomed.com

'/>"/>

SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
2. Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies
3. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
4. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
5. Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
6. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
7. Oxygen Biotherapeutics, Inc. Submits Milestone Achievement Notice to Vatea Fund
8. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
9. Oxygen Biotherapeutics, Inc. to Webcast Shareholder Meeting
10. Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009
11. Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Calif. , Feb. 27, 2017  Titan ... therapeutics for the treatment of select chronic diseases ... today announced that the U.S. Food & Drug ... the ropinirole implant Investigational New Drug Application (IND) ... of the clinical study pending submission of the ...
(Date:2/28/2017)... and SAN FRANCISCO , February 27, 2017 ... Se D BioMedical ... of biotechnology assets   LOI contemplates capital infusion ... for building shareholder value   Amarantus names four new appointees ... Amarantus   SeD Biomedical Inc. (SeD ...
(Date:2/28/2017)... Feb. 27, 2017 Pulmonary drug delivery market ... from USD 36.10 billion in 2016, at a CAGR ... pulmonary route as an alternate route of drug delivery, ... increasing incidence of respiratory diseases such as COPD, asthma, ... growth during the forecast period. However, emerging markets and ...
Breaking Medicine Technology:
(Date:2/28/2017)... IL (PRWEB) , ... February 28, 2017 , ... Today, ... ten years of saving lives by empowering young women to live proactively at a ... 1 in 75 will develop ovarian cancer. Prevention and early detection can save lives-but ...
(Date:2/28/2017)... ... February 28, 2017 , ... The ... America for the scientific development, healthcare training and clinical application of medical infrared ... Session on September 16-17 in Greenville, SC at the Bon Secours St. Francis ...
(Date:2/28/2017)... CA (PRWEB) , ... February 28, 2017 , ... ... Health Coach Institute (HCI) announced a new partnership through which HCI students, ... their coaching curriculum and practices. The partnership also enables the HCI community to ...
(Date:2/28/2017)... ... February 28, 2017 , ... In 2014, Harvard researchers published a report ... from prostate cancer, the researchers found that men who had undergone a vasectomy were ... prostate cancer. Although the increased risks are small, they seem to be contradicted by ...
(Date:2/28/2017)... ... ... Las Vegas Skin and Cancer Clinic (LVSCC) is proud to announce the ... pm PST. For more than six decades, LVSCC has provided the Las Vegas community ... been renovated to provide medical and cosmetic dermatological products and services. Patients at the ...
Breaking Medicine News(10 mins):